Alkaptonuria (AKU) is an ultra-rare disease developed from the lack of homogentisic acid oxidase activity, 26 causing homogentisic acid (HGA) accumulation that produces a HGA-melanin ochronotic pigment, of un-27 known composition. There is no therapy for AKU. Our aim was to verify if AKU implied a secondary amyloid-28 osis. Congo Red, Thioflavin-T staining and TEM were performed to assess amyloid presence in AKU specimens 29 (cartilage, synovia, periumbelical fat, salivary gland) and in HGA-treated human chondrocytes and cartilage. 30 SAA and SAP deposition was examined using immunofluorescence and their levels were evaluated in the pa-31 tients' plasma by ELISA. 2D electrophoresis was undertaken in AKU cells to evaluate the levels of proteins in-32 volved in amyloidogenesis. AKU osteoarticular tissues contained SAA-amyloid in 7/7 patients. Ochronotic 33 pigment and amyloid co-localized in AKU osteoarticular tissues. SAA and SAP composition of the deposits 34 assessed secondary type of amyloidosis. High levels of SAA and SAP were found in AKU patients' plasma. Sys-35 temic amyloidosis was assessed by Congo Red staining of patients' abdominal fat and salivary gland. AKU is 36 the second pathology after Parkinson's disease where amyloid is associated with a form of melanin. Aberrant 37 expression of proteins involved in amyloidogenesis has been found in AKU cells. Our findings on alkaptonuria 38 as a novel type II AA amyloidosis open new important perspectives for its therapy, since methotrexate treat-39 ment proved to significantly reduce in vitro HGA-induced A-amyloid aggregates.
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24
Homogentisic acid 25 Alkaptonuria (AKU) is an ultra-rare disease developed from the lack of homogentisic acid oxidase activity, 26 causing homogentisic acid (HGA) accumulation that produces a HGA-melanin ochronotic pigment, of un-27 known composition. There is no therapy for AKU. Our aim was to verify if AKU implied a secondary amyloid-28 osis. Congo Red, Thioflavin-T staining and TEM were performed to assess amyloid presence in AKU specimens 29 (cartilage, synovia, periumbelical fat, salivary gland) and in HGA-treated human chondrocytes and cartilage. 30 SAA and SAP deposition was examined using immunofluorescence and their levels were evaluated in the pa-31 tients' plasma by ELISA. 2D electrophoresis was undertaken in AKU cells to evaluate the levels of proteins in-32 volved in amyloidogenesis. AKU osteoarticular tissues contained SAA-amyloid in 7/7 patients. Ochronotic 33 pigment and amyloid co-localized in AKU osteoarticular tissues. SAA and SAP composition of the deposits 34 assessed secondary type of amyloidosis. High levels of SAA and SAP were found in AKU patients' plasma. Sys-35 temic amyloidosis was assessed by Congo Red staining of patients' abdominal fat and salivary gland. AKU is 36 the second pathology after Parkinson's disease where amyloid is associated with a form of melanin. Aberrant 37 expression of proteins involved in amyloidogenesis has been found in AKU cells. Our findings on alkaptonuria 38 as a novel type II AA amyloidosis open new important perspectives for its therapy, since methotrexate treat-39 ment proved to significantly reduce in vitro HGA-induced A-amyloid aggregates. 40 
Introduction 46
Alkaptonuria (AKU; MIM no. 203500) is a rare disease (1:250,000-
Secondary amyloid-A (AA) amyloidosis is a serious complication 78 of chronic inflammatory conditions such as rheumatoid arthritis
79
(RA) and its amyloid deposition process involves a cleaved product 80 of the acute-phase protein serum amyloid A (SAA) [14] . AA amyloid-81 osis occurs in patients with poorly controlled chronic inflammatory 82 disease, mainly RA, ankylosing spondylitis, and familial Mediterra-83 nean fever.
84
In the present paper, we provided experimental evidence that
85
AKU osteoarticular tissue contains AA-amyloid deposits. This is the 86 first report, to the best of our knowledge, of secondary amyloidosis 87 associated with AKU. This opens new perspectives for AKU therapy 88 and we also showed that methotrexate was able to significantly pre-89 vent in vitro HGA-induced A-amyloid aggregates.
90
Materials and methods
91
The whole study was conducted following the approval of the 92 local University Hospital Ethics Committee. All patients gave a written 93 informed consent prior to inclusion in the study. FeiTecnai G2 spirit at 80 Kv. (Table 1 , Fig. 4A ,B).
209
High plasma levels of both SAA and SAP were found in all AKU pa-210 tients ( Fig. 4A Alzheimer's disease and its overexpression significantly alters actin dy-292 namics and mitochondrial function in neurons [28] . Gelsolin plays an 293 important role in amyloidogenesis and inhibits amyloid-β fibrillization.
294
A relationship between proteolytic cleavage of gelsolin and increased
295
Aβ in the brain has been recently reported [29] and its decrease corre-
296
lates with rate of decline in Alzheimer's disease [30] . . SAA and SAP were present in amyloid deposits of AKU cartilage and synovia and both co-localized with melanin. A) SAA and SAP deposition in AKU cartilage and synovial specimens was detected by dual immunofluorescence technique. AKU cartilage and synovia showed high levels of SAA deposit superimposing SAP deposits. Positive staining for SAA and SAP was particularly intense in correspondence of ochronotic shards. Bar: 75 μm; B) AKU cartilage sections were dual-stained using antibodies specific for SAA SAP and compared to melanin fluorescence, resulting in a perfect co-localization of amyloid deposits and pigmented areas. Cartilage specimen was from Patient 6 and synovia specimen was from Patient 1. DIC: differential interference contrast. Bar: 150 μm. Representative images from a triplicate set are shown.
expressing HGO may be affected in this disease: joints [36] , heart [5] , 317 kidney [37] , liver [38] , eyes [4] , marrow [39], bladder [40] , and lung
318
[41].
319
It is necessary to correctly define three forms of melanin (two of them 
Remarkably, we found that alkaptonuric amyloid co-localized with may be important producers of amyloid in RA [14] .
333
Reactive systemic AA amyloidosis is one of the most severe complica-
334
tions of several chronic rheumatic disorders [42] . Problems associated AKU mimicking ankylosing spondylitis has been recently reported [4] .
346
Both uveitis and ankylosing spondylitis are SAA secondary amyloidoses.
347
Alkaptonuric arthritis resembles osteoarthritis (OA), but clinically is intra-articular SAA, suggesting an active role in RA pathogenesis [14] .
351
Compared to RA, secondary amyloidosis is a new complication of AKU.
352
We detected AA-amyloid in longstanding AKU patients, confirming am-353 yloidosis to be a progressive disease.
354
Since SAA plasma levels do not correlate with age while SAA serum 355 concentration provides prognostic information [43] , the different SAA Evaluation of the profile of pro-inflammatory cytokines induced by HGA treatment of human chondrocytes and the positive effect of MTX in significantly reducing or restoring control levels of pro-inflammatory cytokines. Cytokine concentrations were calculated using a standard curve established from serial dilutions of each cytokine standard and expressed as pg/mL. Experiments were performed in triplicate; data are presented as average values±standard deviation. cently found to follow a nucleation process in AKU [13] . unfolding and amyloidogenic processes [7] . The under-expression of ca- serving as a precursor of AA amyloid fibrils [23, 47] .
397
It is intriguing that amyloid plays also a fundamental role in the regu-
398
lation of melanin synthesis [48, 49] . Our findings on AKU are, to the best of or a protective response that may slow the disease.
420
We suggest that, analogously to rheumatoid arthritis, AA is a second- been successfully adopted to keep low SAA levels in RA in order to 441 prevent and regress secondary amyloidosis [18] . MTX proved to 
